LSD1 was investigated in breast tumors and detected upregulated LSD1 in estrogen receptor- (ER-) negative tumors [60] and in basal-like breast tumors [61] and it was stated that LSD1 is a prognostic factor of poor outcome in these subtypes. Here, KDM1A is linked to breast neoplasm.